Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Choice and Outcomes for End Stage Renal Disease: Evidence From the First Year of a Nationwide Randomized Evaluation

NCT05005572 is registered in ClinicalTrials.gov with Amy Finkelstein as lead sponsor.

NCT NCT05005572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05005572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Choice and Outcomes for End Stage Renal Disease: Evidence From the First Year of a Nationwide Randomized Evaluation
Lead sponsor
Amy Finkelstein
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2021
Completion date
December 31, 2021
Enrollment
18,621 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease